Bill Few Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,942
Closed -$83.5K 231
2026
Q1
$83.5K Buy
+13,942
New +$105K 0.02% 212
2025
Q4
Sell
-14,318
Closed -$153K 209
2025
Q3
$153K Sell
14,318
-716
-5% -$7.03K 0.04% 201
2025
Q2
$146K Buy
15,034
+691
+5% +$7.13K 0.04% 194
2025
Q1
$214K Buy
14,343
+477
+3% +$7.34K 0.08% 168
2024
Q4
$207K Buy
13,866
+1,283
+10% +$20.9K 0.07% 168
2024
Q3
$241K Buy
12,583
+365
+3% +$7.57K 0.09% 155
2024
Q2
$253K Buy
12,218
+621
+5% +$12.3K 0.1% 146
2024
Q1
$218K Buy
+11,597
New +$199K 0.09% 157

Other funds holding OGN

Bill Few Associates's OGN Position: Q2 2026 in Review

Bill Few Associates sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 13,942 shares — an estimated $83.5K sold.

Bill Few Associates first reported a position in OGN in Q1 2024 and held it in 8 quarters. The position peaked at $253K in Q2 2024. 115 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Bill Few Associates reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Bill Few Associates sold 13,942 Organon & Co shares in Q2 2026, an estimated $83.5K.
  • Bill Few Associates first reported a position in Organon & Co in Q1 2024 and held it in 8 quarters.
  • Bill Few Associates's Organon & Co position peaked at $253K in Q2 2024.
  • 115 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.